跳至主要内容
临床试验/NCT03898154
NCT03898154招募中4 期

The Effect on Wrist Range of Motion With Perioperative Glucocorticoid Administration in the Treatment of Adult Distal Radius Fractures: A Randomized Controlled Trial

C. Liam Dwyer1 个研究点 分布在 1 个国家目标入组 200 人开始时间: 2019年7月10日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
招募中
发起方
入组人数
200
试验地点
1
主要终点
QuickDASH

研究概览

简要总结

The purpose of this investigation is to compare functional outcome measures and range of motion for patients receiving glucocorticoid (GC) injections versus those not receiving GCs for the treatment of distal radius fractures. The investigators hypothesize that patients who receive GC will have improved ROM and functional outcome measures compared to patients who do not receive GC. In addition, this study aims to determine if there is a difference in rates of complications and postoperative pain control between the GC and non-GC groups. In order to accomplish these aims, the investigators will conduct a prospective, randomized, controlled investigation.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patient 18 years of age and older.
  • Patients undergoing ORIF with VP fixation of an acute, isolated DRF with or without associated distal ulna fracture and with or without associated carpal tunnel release

排除标准

  • Worker's compensation patient
  • Non-operatively treated fractures
  • Open fractures
  • Preoperative neurovascular injury
  • Coexisting fractures or injuries
  • Diabetes mellitus
  • Allergy or contraindication to GCs
  • Associated non-orthopedic injury that would prohibit the administration of GCs
  • Patients currently incarcerated
  • Pregnant patients

研究组 & 干预措施

Glucocorticoid (GC) group

Experimental

Intraoperative: Single intraoperative dose of 10 mg intravenous dexamethasone Postoperative: A 6-day oral methylprednisolone (oral GC) taper course. The oral GC taper course begins on the day of surgery and includes 24mg on day 1, 20mg on day 2, 16mg on day 3, 12mg on day 4, 8mg on day 5, and 4mg on day 6

干预措施: Dexamethasone (Drug)

Glucocorticoid (GC) group

Experimental

Intraoperative: Single intraoperative dose of 10 mg intravenous dexamethasone Postoperative: A 6-day oral methylprednisolone (oral GC) taper course. The oral GC taper course begins on the day of surgery and includes 24mg on day 1, 20mg on day 2, 16mg on day 3, 12mg on day 4, 8mg on day 5, and 4mg on day 6

干预措施: Methylprednisolone (Drug)

结局指标

主要结局

QuickDASH

时间窗: 0-12 months

best 0-100 worst; functional outcome score for disabilities of the arm, shoulder, and hand

Visual Analog Scale Pain Score

时间窗: 0-12 months

best 0-10 worst; continuous scale to measure current pain level

PROMIS Self-Efficacy Manage Symptoms

时间窗: 0-12 months

best 0-100 worst; measures a patient's ability to cope with their symptoms related to the procedure

PROMIS Pain Interference

时间窗: 0-12 months

best 0-100 worst; measures the effects of a patient's pain on their daily activities and lifestyle

PROMIS Upper Extremity

时间窗: 0-12 months

worst 0-100 best; measures physical function of upper extremities

次要结局

未报告次要终点

研究者

发起方
C. Liam Dwyer
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

C. Liam Dwyer

Staff Physician

Geisinger Clinic

研究点 (1)

Loading locations...

相似试验